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1. General 
Recombinant histidine-tagged phenylacetone mononoxygenase (PAMO), its M446G mutant 
(M446G-PAMO) and recombinant 4-hydroxyacetophenone monooxygenase (HAPMO) were 
overexpressed and purified as previously described.[1] 1.0 Unit of BVMO will oxidise 1.0 µmol 
of phenylacetone to benzyl acetate per minute at pH 9.0 and room temperature in the presence of 
NADPH. Glucose 6-phosphate dehydrogenase from Leuconostoc mesenteroides was obtained 
from Fluka-Biochemika. Starting racemic α-alkyl-β-ketoesters rac-2a, rac-6a and enantiopure 
hydroxyesters (S)-1-3c and (S)-10c were obtained from Sigma-Aldrich-Fluka, whereas rac-5a 
was purchased from Alfa Aesar. All other reagents and solvents were of the highest quality grade 
available and were acquired from Sigma-Aldrich-Fluka and Acros Organics. Chemical reactions 
were monitored by analytical TLC, performed on Merck silica gel 60 F254 plates and visualised 
by UV irradiation. Flash chromatography was carried out with silica gel 60 (230-240 mesh, 
Merck). IR spectra were recorded on a Perkin-Elmer 1720-X infrared Fourier transform 
spectrophotometer using KBr pellets. 1H-NMR, 13C-NMR and DEPT spectra were recorded with 
tetramethylsilane (TMS) as the internal standard with a Bruker AC-300 DPX (1H: 300.13 MHz; 
13C: 75.5 MHz) spectrometer. The chemical shift values () are given in ppm. Optical rotations 
were measured using a Perkin-Elmer 241 polarimeter and are quoted in units of 10-1 deg cm2 g-1. 
APCI+ and ESI+ using a Hewlett Packard 1100 chromatograph mass detector or EI+ with a 
Hewlett Packard 5973 mass spectrometer were used to record mass spectra (MS). High-
resolution mass spectra were obtained with a Bruker Microtof-Q-spectrometer. Kinetic 




2. Experimental procedures 
2.1. Enzymatic Baeyer-Villiger oxidation of racemic α-alkyl-β-ketoesters. 
Racemic compounds rac-1-10a (10 mM) were dissolved in a Tris-HCl buffer (50 mM, pH 8.0 or 
9.0, 1.0 mL) containing 1% v v-1 DMSO. Then, NADPH (0.2 mM), glucose-6-phosphate (20 mM), 
glucose-6-phosphate dehydrogenase (5 U) and the BVMO (1 U) were added. The mixture was 
shaken at 250 rpm at the selected temperature. Reactions were stopped by extraction with ethyl 
acetate (2  0.5 mL) and the organic layer was dried over Na2SO4. Conversions and enantiomeric 
excesses of compounds (S)-1-10b were determined by GC or HPLC analysis (Table S1). 
Table S1. BVMO-catalysed Baeyer-Villiger oxidation of racemic α-alkyl-β-ketoesters. 
Entry Substrate BVMO T (ºC) c [%][a] ee [%][b] 
1[c] rac-1a PAMO 30 28 ≥99(S) 
2 rac-1a M446G 30 15 ≥99(S) 
3 rac-2a HAPMO 20 28 ≥99(S) 
4 rac-2a M446G 30 25 ≥99(S) 
5 rac-3a HAPMO 20 5 ≥99(S) 
6 rac-3a M446G 30 36 ≥99(S) 
7 rac-4a HAPMO 20 30 82(S) 
8 rac-4a M446G 30 7 ≥99(S) 
9 rac-8a M446G 30 59 ≥99(S) 
10 rac-10a M446G 30 22 ≥99(S) 
 
[a] Determined by GC.[b] Determined by GC or HPLC. [c] Reaction carried out at pH 8.0. 
 
2.2. Study of the substrate concentration in the PAMO-catalysed oxidation of rac-7a employing 
two different reaction media. 
Racemic isopropyl 2-ethyl-3-oxobutanoate (1.7-13.8 g L-1) was dissolved in two different reaction 
media: a) Tris-HCl buffer (50 mM, pH 9.0, 1.0 mL) containing 1% v v-1 DMSO or b) Tris-HCl 
buffer (50 mM, pH 9.0, 0.95 mL) containing 5% v v-1 TBME (50 µL) and 1% v v-1 DMSO. Then, 
NADPH (0.2 mM), glucose-6-phosphate (20 mM), glucose-6-phosphate dehydrogenase (5 U) and 
PAMO (1 U) were added. The mixture was shaken at 250 rpm at 30ºC during 48 hours. Reactions 
were then stopped by extraction with EtOAc (2  0.5 mL) and the organic layer was dried over 
Na2SO4. Conversions and enantiomeric excesses of compounds (S)-7b were determined by GC or 
HPLC analysis. The space time yields (expressed as mg of 7a consumed per L of solution per h) 




Figure S1. Effect of rac-7a concentration in the space time yield while using as reaction medium: Tris-
HCl 50 mM pH 9.0 (▲, solid line) and Tris-HCl 50 mM pH 9.0 containing 5% v v-1 TBME (♦, dashed 
line). 
 
2.3. Baeyer-Villiger oxidation of rac-1-10a at multimilligram scale catalysed by PAMO. 
α-Alkyl-β-ketoesters rac-1-10a (50 mg, 1 equiv.) were dissolved in a Tris-HCl buffer (50 mM, pH 
9.0, 13.0 mL) containing 1% v v-1 DMSO. Then, NADPH (0.2 mM), glucose-6-phosphate (40 
mM), glucose-6-phosphate dehydrogenase (150 units) and PAMO (30 units) were added. The 
reactions were stirred at 250 rpm and 30ºC and stopped after 24 hours by extraction with ethyl 
acetate (3  10 mL). The organic layer was dried over Na2SO4 and the solvent was evaporated. No 
further purification was required, except for substrates rac-4b and rac-5b, which were purified by 
flash chromatography on silica gel using hexane/ethyl acetate 9:1 as eluent. All the final products 
(S)-1-10b were achieved enantiopure except (S)-9b, which was isolated with ee=50%: (S)-1b 
(70% yield, 39.3 mg), (S)-2b (62% yield, 35.1 mg), (S)-3b (59% yield, 32.8 mg), (S)-4b (68% 
yield, 38.3 mg), (S)-5b (65% yield, 36.0 mg), (S)-6b (61% yield, 33.4 mg), (S)-7b (63% yield, 
34.4 mg), (S)-8b with (65% yield, 35.6 mg), (S)-9b (74% yield, 39.6 mg), and (S)-10b with (76% 
yield, 41.0 mg).  
Compounds 1a,[2a] and 2b[2b] exhibit physical and spectral properties in accord with those 
reported. 
(S)-Methyl 2-acetoxypropanoate, (S)-1b. Rf (8:2 hexane-EtOAc): 0.28. Colourless liquid. IR 
(KBr):  2998, 1741, 1643, 1454, and 1237 cm
-1
. 1H-NMR (300.13 MHz, CDCl3, 25ºC):  1.46 
(d, 3JH,H 7.2 Hz, 3H), 2.11 (s, 3H), 3.73 (s, 3H), 5.07 (q, 
3
JH,H 7.2 Hz, 1H). 
13C-NMR (75.5 MHz, 
CDCl3, 25ºC):  16.8 (CH3), 20.6 (CH3), 52.2 (CH3), 68.4 (CH), 170.3 (CO), 171.2 (CO). MS 
(ESI+, m/z): 169 [(M+Na)+, 24%]. 
(S)-Ethyl 2-acetoxypropanoate, (S)-2b. Rf (8:2 hexane-EtOAc): 0.32. Colourless liquid. IR 
(KBr):  2997, 1743, 1640, 1441, and 1370 cm
-1




JH,H 7.2 Hz, 3H), 1.47 (d, 
3
JH,H 7.0 Hz, 3H), 2.12 (s, 3H), 4.19 (q, 
3
JH,H 7.2 Hz, 2H), 5.10 (q, 
3
JH,H 
7.0 Hz, 1H). 13C-NMR (75.5 MHz, CDCl3, 25ºC):  14.0 (CH3), 16.8 (CH3), 20.6 (CH3), 61.3 
(CH2), 68.6 (CH), 170.3 (CO), 171.2 (CO). MS (ESI
+, m/z): 183 [(M+Na)+, 100%]. 
(S)-Isopropyl 2-acetoxypropanoate, (S)-3b. Rf (8:2 hexane-EtOAc): 0.34. Colourless liquid. IR 
(KBr):  2986, 1745, 1455, 1386, and 1200 cm
-1
. 1H-NMR (300.13 MHz, CDCl3, 25ºC):  1.23 
(d, 3JH,H 6.4 Hz, 3H), 1.24 (d, 
3
JH,H 6.4 Hz, 3H), 1.45 (d, 
3
JH,H 7.0 Hz, 3H), 2.11 (s, 3H), 4.97-5.08 
(m, 2H). 13C-NMR (75.5 MHz, CDCl3, 25ºC):  16.8 (2CH3), 20.6 (CH3), 21.5 (CH3), 68.7 (CH), 
68.9 (CH), 166.3 (CO), 170.3 (CO). MS (ESI+, m/z): 197 [(M+Na)+, 92%]. HRMS (ESI+) calcd. 
for C8H14NaO4 (M+Na)
+: 197.0784; found: 197.0776. [α]D
25= -37.9 (c 1.00, CHCl3), ee = 99%. 
(S)-Methyl 2-propionyloxypropanoate, (S)-4b. Rf (8:2 hexane-EtOAc): 0.34. Colourless liquid. 
IR (KBr):  2991, 1746, 1461, 1305, and 1277 cm
-1
. 1H-NMR (300.13 MHz, CDCl3, 25ºC):  
1.15 (t, 3JH,H 7.5 Hz, 3H), 1.47 (d, 
3
JH,H 7.0 Hz, 3H), 2.36-2.47 (m, 2H), 3.73 (s, 3H), 5.08 (q, 
3
JH,H 
7.0 Hz, 1H). 13C-NMR (75.5 MHz, CDCl3, 25ºC):  8.8 (CH3), 16.9 (CH3), 27.2 (CH2), 52.2 
(CH3), 68.3 (CH), 171.3 (CO), 173.8 (CO). MS (ESI
+, m/z): 183 [(M+Na)+, 50%]. HRMS (ESI+) 
calcd. for C7H12NaO4 (M+Na)
+: 183.0628; found: 183.0619. [α]D
25= -34.6 (c 1.00 CHCl3), ee = 
99%. 
(S)-Methyl 2-acetoxybutanoate, (S)-5b. Rf (8:2 hexane-EtOAc): 0.34. Colourless liquid. IR 
(KBr):  2957, 1746, 1440, 1376, and 1235 cm
-1
. 1H-NMR (300.13 MHz, CDCl3, 25ºC):  0.96 (t, 
3
JH,H 7.4 Hz, 3H), 1.79-1.90 (m, 2H), 2.11 (s, 3H), 3.72 (s, 3H), 4.91-4.95 (m, 1H). 
13C-NMR 
(75.5 MHz, CDCl3, 25ºC):  9.4 (CH3), 20.5 (CH3), 24.4 (CH2), 52.0 (CH3), 73.2 (CH), 170.5 
(CO), 170.6 (CO). MS (ESI+, m/z): 183 [(M+Na)+, 34%]. HRMS (ESI+) calcd. for C7H12NaO4 
(M+Na)+: 183.0628; found: 183.0637. [α]D
25= -25.0 (c 0.90, CHCl3), ee = 99%. 
(S)-Ethyl 2-acetoxybutanoate, (S)-6b. Rf (8:2 hexane-EtOAc): 0.36. Colourless liquid. IR (KBr): 
 2980, 1744, 1464, 1375, and 1234 cm
-1
. 1H-NMR (300.13 MHz, CDCl3, 25ºC):  0.96 (t, 
3
JH,H 
7.4 Hz, 3H), 1.25 (t, 3JH,H 7.2 Hz, 3H), 1.79-1.90 (m, 2H), 2.10 (s, 3H), 4.17 (q, 
3
JH,H 7.2 Hz, 2H), 
4.88-4.92 (m, 1H). 13C-NMR (75.5 MHz, CDCl3, 25ºC):  9.4 (CH3), 14.0 (CH3), 20.5 (CH3), 24.4 
(CH2), 61.1 (CH2), 73.3 (CH), 170.1 (CO), 170.5 (CO). MS (ESI
+, m/z): 197 [(M+Na)+, 70%]. 
HRMS (ESI+) calcd. for C8H14NaO4 (M+Na)
+: 197.0782; found: 197.0784. [α]D
25= -28.7. (c 1.00, 
CHCl3), ee = 99%. 
(S)-Isopropyl 2-acetoxybutanoate, (S)-7b. Rf (8:2 hexane-EtOAc): 0.41. Colourless liquid. IR 
(KBr):  2989, 1745, 1464, 1426, 1375, 1234, and 1207 cm
-1
. 1H-NMR (300.13 MHz, CDCl3, 
25ºC):  0.96 (t, 3JH,H 7.4 Hz, 3H), 1.22 (d, 
3
JH,H 6.3 Hz, 3H), 1.23 (d, 
3
JH,H 6.8 Hz, 3H), 1.77-1.88 
(m, 2H), 2.10 (s, 3H), 4.84-4.88 (m, 1H), 4.99-5.08 (m, 1H). 13C-NMR (75.5 MHz, CDCl3, 25ºC): 
S6 
 
 9.3 (CH3), 20.5 (CH3), 21.5 (CH3), 21.6 (CH3), 24.3 (CH2), 68.8 (CH), 73.4 (CH), 169.6 (CO), 
170.5 (CO). MS (ESI+, m/z): 211 [(M+Na)+, 52%]. HRMS (ESI+) calcd. for C9H16NaO4 (M+Na)
+: 
211.0946; found: 211.0948. [α]D
25= -38.7 (c 0.98, CHCl3), ee = 99%. 
(S)-Ethyl 2-acetoxypent-4-enoate, (S)-8b. Rf (8:2 hexane-EtOAc): 0.44. Colourless liquid. IR 
(KBr):  3080, 2983, 1800, 1643, 1469, and 1431 cm
-1. 1H-NMR (300.13 MHz, CDCl3, 25ºC):  
1.25 (t, 3JH,H 7.0 Hz, 3H), 2.20 (s, 3H), 2.54-2.60 (m, 2H), 4.18 (q, 
3
JH,H 7.0 Hz, 2H), 5.01-5.06 
(m, 1H), 5.08-5.28 (m, 2H), 5.72-5.79 (m, 1H). 13C-NMR (75.5 MHz, CDCl3, 25ºC):  14.0 
(CH3), 20.5 (CH3), 35.4 (CH2), 61.3 (CH2), 71.6 (CH), 118.6 (CH2), 131.9 (CH), 169.5 (CO), 
170.3 (CO). MS (ESI+, m/z): 209 [(M+Na)+, 30%]. HRMS (ESI+) calcd. for C9H14NaO4 (M+Na)
+: 
209.0784; found: 209.0767. [α]D
25= -17.3 (c 1.12, CHCl3), ee = 99%. 
(S)-Isopropyl 2-acetoxy-3-phenylpropanoate, (S)-9b. Rf (8:2 hexane-EtOAc): 0.29. Pale yellow 
liquid. IR (KBr):  3030, 2934, 1731, 1496, 1455, and 1375 cm
-1
. 1H-NMR (300.13 MHz, CDCl3, 
25ºC):  1.17 (d, 3JH,H 6.4 Hz, 3H), 1.23 (d, 
3
JH,H 6.4 Hz, 3H), 2.09 (s, 3H), 3.10 (dd, 
2
JH,H 11.6 
Hz, 3JH,H 8.6 Hz, 1H), 3.16 (dd, 
2
JH,H 11.6 Hz, 
3
JH,H 5.0 Hz, 1H), 4.98-5.07 (m, 
3
JH,H 6.4 Hz, 1H), 
5.16 (dd, 3JH,H 8.6 Hz, 
3
JH,H 5.0 Hz, 1H), 7.23-7.31 (m, 5H). 
13C-NMR (75.5 MHz, CDCl3, 25ºC): 
 20.5 (CH3), 21.5 (CH3), 21.6 (CH3), 37.2 (CH2), 69.1 (CH), 73.1 (CH), 126.9 (CHar), 128.3 
(2CHar), 129.3 (2CHar), 135.9 (Car), 169.1 (CO), 170.3 (CO). MS (ESI
+, m/z): 273 [(M+Na)+, 
100%]. HRMS (ESI+) calcd. for C14H18NaO4 (M+Na)
+: 273.1097; found: 273.1105. [α]D
25= -5.7 
(c 1.05, CHCl3), ee = 54%. 
(S)-Benzyl 2-acetoxypropanoate, (S)-10b. Rf (8:2 hexane-EtOAc): 0.31. Pale yellow liquid. IR 
(KBr):  3035, 2994, 1744, 1455, 1305, 1257, and 1196 cm
-1. 1H-NMR (300.13 MHz, CDCl3, 
25ºC):  1.49 (d, 3JH,H 7.0 Hz, 3H), 2.12 (s, 3H), 5.09-5.16 (m, 1H), 5.17 (s, 2H), 7.33-7.36 (m, 
5H). 13C-NMR (75.5 MHz, CDCl3, 25ºC):  16.8 (CH3), 20.6 (CH3), 66.9 (CH2), 68.5 (CH), 128.0 
(2CHar), 128.3 (2CHar), 135.3 (CHar), 166.3 (Car), 170.3 (CO), 170.6 (CO). MS (ESI
+, m/z): 245 
[(M+Na)+, 55%]. HRMS (ESI+) calcd. for C12H14NaO4 (M+Na)
+: 245.0784; found: 245.0795. 
[α]D
25= -91.4 (c 1.00, CHCl3), ee = 99%. 
 
2.4. General procedure for the enzymatic hydrolysis of rac-isopropyl 2-acetoxybutanoate, rac-7b. 
In a typical experiment, to a solution of compound rac-7b (9.4 mg, 1.0 equiv) in a Tris-HCl buffer 
(50 mM, pH 9.0, 500 µL), 9.4 mg of commercially available hydrolase (CAL-A, CRL, PPL, SD, 
PLE, subtilisin, CAL-B, AK, IM) was added. The reaction was shaken at 30°C and 250 rpm in a 
rotator shaker for the times established (3.5 hours or 7 hours), stopped by extraction with EtOAc 
S7 
 
containing 1 mg mL-1 mesitylene (2 x 400 µL) and dried over Na2SO4. Conversions and 
enantiomeric excesses of the reactions were measured by GC and HPLC analysis. 
For CRL, PLE, subtilisin and CAL-B, it was observed the disappearance of rac-7b, but expected 
product rac-7c was not obtained. PPL led to rac-7c with very low conversions. Lipases AK and 
IM were not able to hydrolyse the S enantiomer of rac-7b while lipases CAL-A and SD were not 
regioselectivity in the process, being achieved other hydrolysis products.  
 
2.5. Procedure for the chemical hydrolysis of diesters (S)-3-9b. 
To a solution of the corresponding diester (25 mg, 1.0 equiv.) in 5.0 mL of MeOH, EtOH or 
iPrOH, traces of HCl were added. The reaction was refluxed and followed by TLC using CH2Cl2 
as eluent. After disappearance of the starting product, the reaction was stopped and the solvent 
was evaporated under reduced pressure. (S)-α-hydroxyesters were obtained without any further 
purification. All the products were achieved enantiopure except for (S)-9c, isolated with ee=54%. 
(S)-3c (60% yield, 11.3 mg), (S)-4c (60% yield, 9.8 mg), (S)-5c was obtained with 64% yield 
(11.8 mg), (S)-6c with 70% yield (13.2 mg), (S)-7c with 65% yield (12.6 mg), (S)-8c with 70% 
yield (13.5 mg), and (S)-9c with 85% yield (17.6 mg).  
Compounds 5c,[3a] and 6c[3b] exhibit physical and spectral properties in accordance with those 
reported. 
(S)-Isopropyl 2-hydroxypropanoate, (S)-3c. Rf (8:2 hexane-EtOAc): 0.20. Colourless liquid. IR 
(KBr):  3480, 2984, 1651, 1463, 1376, and 1271 cm
-1
. 1H-NMR (300.13 MHz, CDCl3, 25ºC):  
1.24 (d, 3JH,H 6.1 Hz, 3H), 1.25 (d, 
3
JH,H 6.4 Hz, 3H), 1.37 (d, 
3
JH,H 6.4 Hz, 3H), 2.94 (s, 1H), 4.15-
4.23 (m, 1H), 5.02-5.10 (m, 1H). 13C-NMR (75.5 MHz, CDCl3, 25ºC):  20.3 (CH3), 21.6 (2CH3), 
66.7 (CH), 69.3 (CH), 175.2 (CO). MS (ESI+, m/z): 155 [(M+Na)+, 73%]. HRMS (ESI+) calcd. for 
C6H12NaO3 (M+Na)
+: 155.0684; found: 155.0687. [α]D
25= -5.20 (c 1.00, CHCl3), ee = 99%.
[4a] 
(S)-Methyl 2-hydroxybutanoate, (S)-5c. Rf (8:2 hexane-EtOAc): 0.20. Colourless liquid. IR 
(KBr):  3433, 2969, 1738, 1645, 1420, 1296, and 1135 cm
-1
. 1H-NMR (300.13 MHz, CDCl3, 
25ºC):  0.95 (t, 3JH,H 7.4 Hz, 3H), 1.60-1.89 (m, 2H), 2.77 (d, 
3
JH,H 5.9 Hz, 1H), 3.78 (s, 3H), 
4.15 (q, 3JH,H 5.9 Hz, 1H). 
13C-NMR (75.5 MHz, CDCl3, 25ºC):  8.8 (CH3), 27.4 (CH2), 52.4 
(CH3), 71.4 (CH), 175.6 (CO). MS (ESI
+, m/z): 141 [(M+Na)+, 40%]. [α]D
25= -6.4 (c 1.15, 
CHCl3), ee = 99%.
[4b] 
(S)-Ethyl 2-hydroxybutanoate, (S)-6c. Rf (8:2 hexane-EtOAc): 0.21. Colourless liquid. IR 
(KBr):  3429, 2980, 1733, 1600, 1464, and 1212 cm
-1
. 1H-NMR (300.13 MHz, CDCl3, 25ºC):  
0.96 (t, 3JH,H 7.3 Hz, 3H), 1.29 (t, 
3
JH,H 7.1 Hz, 3H), 1.63-1.88 (m, 2H), 2.77 (d, 
3
JH,H 5.7 Hz, 1H), 
S8 
 
4.10-4.16 (m, 1H), 4.24 (q, 3JH,H 7.1 Hz, 2H). 
13C-NMR (75.5 MHz, CDCl3, 25ºC):  8.7 (CH3), 
14.1 (CH3), 27.4 (CH2), 61.6 (CH2), 71.3 (CH), 175.2 (CO). MS (ESI
+, m/z): 155 [(M+Na)+, 
36%]. [α]D
25= -5.95 (c 1.20, CH3CH2OH), ee = 99%.
[3b] 
(S)-Isopropyl 2-hydroxybutanoate, (S)-7c. Rf (8:2 hexane-EtOAc): 0.31. Colourless liquid. IR 
(KBr):  3413, 2982, 1731, 1463, 1376, and 1107 cm
-1
. 1H-NMR (300.13 MHz, CDCl3, 25ºC):  
0.94 (t, 3JH,H 7.4 Hz, 3H), 1.25 (d, 
3
JH,H 6.3 Hz, 3H), 1.27 (d, 
3
JH,H 6.3 Hz, 3H), 1.64-1.71 (m, 1H), 
1.77-1.81 (m, 1H), 2.80 (d, 3JH,H 5.7 Hz, 1H), 4.09-4.10 (m, 1H), 5.09 (m, 
3
JH,H 6.3 Hz, 1H). 
13C-
NMR (75.5 MHz, CDCl3, 25ºC):  8.7 (CH3), 21.7 (2CH3), 27.4 (CH2), 69.3 (CH), 71.3 (CH), 
174.7 (CO). MS (ESI+, m/z): 169 [(M+Na)+, 61%]. HRMS (ESI+) calcd for C7H14NaO3 (M+Na)
+: 
169.0835; found: 169.0838. [α]D
25= -6.1 (c 0.85, CHCl3), ee = 99%. 
(S)-Ethyl 2-hydroxypent-4-enoate, (S)-8c. Rf (8:2 hexane-EtOAc): 0.23. Colourless liquid. IR 
(KBr):  3409, 2984, 1747, 1376, and 1243 cm
-1
. 1H-NMR (300.13 MHz, CDCl3, 25ºC):  1.29 (t, 
3
JH,H 7.2 Hz, 3H), 2.38-2.48 (m, 1H), 2.52-2.61 (m, 1H), 2.81 (d, 1H), 4.20-4.28 (m, 3H), 5.11-
5.18 (m, 2H), 5.73-5.87 (m, 1H). 13C-NMR (75.5 MHz, CDCl3, 25ºC):  14.0 (CH3), 38.5 (CH2), 
61.4 (CH2), 69.8 (CH), 118.4 (CH2), 132.4 (CH), 174.2 (CO). MS (ESI
+, m/z): 167 [(M+Na)+, 
67%]. [α]D
25= -4.2 (c 0.95, CHCl3), ee = 99%.  
(S)-Isopropyl 2-hydroxy-3-phenylpropanoate, (S)-9c. Rf (8:2 hexane-EtOAc): 0.23. Colourless 
liquid. IR (KBr):  3359, 3088, 2982, 1731, 1496, 1375, and 1273 cm
-1
. 1H-NMR (300.13 MHz, 
CDCl3, 25ºC):  1.26 (d, 
3
JH,H 6.1 Hz, 3H), 1.28 (d, 
3
JH,H 6.1 Hz, 3H), 2.99 (dd, 
2
JH,H 13.8 Hz, 
3
JH,H 6.8 Hz, 1H), 3.15 (dd, 
2
JH,H 13.8 Hz, 
3
JH,H 4.8 Hz, 1H), 4.43 (m, 1H), 5.08 (m, 
3
JH,H 6.1 Hz, 
1H), 7.20-7.36 (m, 5H). 13C-NMR (75.5 MHz, CDCl3, 25ºC):  21.6 (2CH3), 40.3 (CH2), 69.4 
(CH), 71.1 (CH), 126.7 (CHar), 128.1 (2CHar), 129.4 (2CHar), 136.3 (Car), 173.6 (CO). MS (ESI
+, 
m/z): 231 [(M+Na)+, 100%]. HRMS (ESI+) calcd. for C12H16NaO3 (M+Na)
+: 231.0992; found: 
231.0995. [α]D
25= -9.7 (c 0.78, CHCl3), ee = 99%. 
 
2.6. General procedure for the synthesis of racemic α-alkyl-β-ketoesters rac-1a, rac-3-4a, rac-7-
10a.[5] 
A mixture of the corresponding alkyl acetoacetate or methyl-3-oxo-pentanoate (2.0 g, 1.0 equiv) 
and anhydrous powdered K2CO3 (1.3 equiv) in 20.0 mL of dry acetone was stirred under nitrogen 
atmosphere for five minutes. Then, methyl iodide, ethyl iodide, allyl bromide or benzyl bromide 
(1.3 equiv) was added carefully. The reaction was refluxed for 18 hours. The crude mixture was 
then filtered and the solvent evaporated under reduced pressure. The residues were purified by 
flash chromatography on silica gel with hexane/ethyl acetate 9:1 to afford methyl 2-methyl-3-
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oxobutanoate rac-1a (67% yield, 1.54 g), isopropyl 2-methyl-3-oxobutanoate rac-3a (81% yield, 
1.80 g), methyl 2-methyl-3-oxopentanoate rac-4a (29% yield, 0.64 g), isopropyl 2-ethyl-3-
oxobutanoate rac-7a (42% yield, 0.91 g), ethyl 2-acetylpent-4-enoate rac-8a (84% yield, 1.84 g), 
isopropyl 2-benzyl-3-oxobutanoate rac-9a (53% yield, 1.13 g), and benzyl 2-methyl-3-
oxobutanoate rac-10a (47% yield, 1.01 g). 
Compounds rac-1a,[6a] rac-3a,[6b], rac-8a,[6c] and rac-10a,[6d] exhibit physical and spectral 
properties in accord with those reported.  
rac-Methyl 2-methyl-3-oxobutanoate, rac-1a. Rf (8:2 hexane-EtOAc): 0.27. Colourless liquid. 
IR (KBr):  2999, 1750, 1720, 1380, and 1359 cm
-1
. 1H-NMR (300.13 MHz, CDCl3, 25ºC):  
1.35 (d, 3JH,H 7.2 Hz, 3H), 2.23 (s, 3H), 3.51 (q, 
3
JH,H 7.2 Hz, 1H), 3.79 (s, 3H). 
13C-NMR (75.5 
MHz, CDCl3, 25ºC):  12.7 (CH3), 28.3 (CH3), 52.2 (CH3), 53.3 (CH), 170.8 (CO), 203.5 (CO). 
MS (ESI+, m/z): 153 [(M+Na)+, 56%].  
rac-Isopropyl 2-methyl-3-oxobutanoate, rac-3a. Rf (8:2 hexane-EtOAc): 0.41. Colourless 
liquid. IR (KBr):  2942, 1738, 1715, 1455, 1376, and 1359 cm
-1
. 1H-NMR (300.13 MHz, CDCl3, 
25ºC):  1.24 (d, 3JH,H 6.1 Hz, 6H), 1.28 (d, 
3
JH,H 7.0 Hz, 3H), 2.20 (s, 3H), 3.44 (q, 
3
JH,H 7.0 Hz, 
1H), 4.27-5.29 (m, 1H). 13C-NMR (75.5 MHz, CDCl3, 25ºC):  12.6 (CH3), 21.4 (2CH3), 28.3 
(CH3), 53.8 (CH), 68.8 (CH), 170.0 (CO), 203.6 (CO). MS (ESI
+, m/z): 181 [(M+Na)+, 53%].  
rac-Methyl 2-methyl-3-oxopentanoate, rac-4a. Rf (8:2 hexane-EtOAc): 0.37. Colourless liquid. 
IR (KBr):  2984, 2940, 1747, 1594, 1455, and 1435 cm
-1
. 1H-NMR (300.13 MHz, CDCl3, 25ºC): 
 1.06 (t, 3JH,H 7.2 Hz, 3H), 1.34 (d, 
3
JH,H 7.0 Hz, 3H), 2.52-2.59 (m, 2H), 3.52 (q, 
3
JH,H 7.2 Hz, 
1H), 3.71 (s, 3H). 13C-NMR (75.5 MHz, CDCl3, 25ºC):  7.6 (CH3), 12.8 (CH3), 34.6 (CH2), 52.3 
(CH), 52.4 (CH3), 171.1 (CO), 206.3 (CO). MS (ESI
+, m/z): 167 [(M+Na)+, 76%]. HRMS (ESI+) 
calcd for C7H12NaO3 (M+Na)
+: 167.0679; found: 167.0671. 
rac-Isopropyl 2-ethyl-3-oxobutanoate, rac-7a. Rf (8:2 hexane-EtOAc): 0.46. Colourless liquid. 
IR (KBr):  2980, 1736, 1714, 1463, 1375, and 1359 cm
-1
. 1H-NMR (300.13 MHz, CDCl3, 25ºC): 
 0.82 (t, 3JH,H 7.5 Hz, 3H), 1.14 (d, 
3
JH,H 6.4 Hz, 3H), 1.15 (d, 
3
JH,H 6.2 Hz, 3H), 1.71-1.82 (m, 
2H), 2.10 (s, 3H), 3.18-3.22 (t, 3JH,H 7.2 Hz, 1H), 4.94-5.22 (m, 1H). 
13C-NMR (75.5 MHz, 
CDCl3, 25ºC):  11.5 (CH3), 21.2 (CH3), 21.3 (CH3), 21.4 (CH2), 28.4 (CH3), 61.3 (CH), 68.4 
(CH), 169.0 (CO), 203.6 (CO). MS (ESI+, m/z): 195 [(M+Na)+, 28%]. HRMS (ESI+) calcd. for 
C9H16NaO3 (M+Na)
+: 195.0992; found: 195.0993. 
rac-Ethyl 2-acetylpent-4-enoate, rac-8a. Rf (8:2 hexane-EtOAc): 0.28. Colourless liquid. IR 
(KBr):  3081, 2983, 1743, 1715, 1643, 1441, and 1367 cm
-1
. 1H-NMR (300.13 MHz, CDCl3, 
25ºC):  1.25 (t, 3JH,H 7.0 Hz, 3H), 2.21 (s, 3H), 2.54-2.59 (m, 2H), 3.50 (t, 
3
JH,H 7.5 Hz, 1H), 4.18 
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(q, 3JH,H 7.0 Hz, 2H), 5.01-5.28 (m, 2H), 5.65-5.79 (m, 1H). 
13C-NMR (75.5 MHz, CDCl3, 25ºC): 
 14.0 (CH3), 28.9 (CH3), 32.1 (CH2), 59.1 (CH), 61.3 (CH2), 117.3 (CH2), 132.1 (CH), 169.1 
(CO), 202.4 (CO). MS (ESI+, m/z): 193 [(M+Na)+, 100%].  
rac-Isopropyl 2-benzyl-3-oxobutanoate, rac-9a. Rf (8:2 hexane-EtOAc): 0.43. Colourless liquid. 
IR (KBr):  3056, 2982, 1738, 1715, 1496, and 1455 cm
-1
. 1H-NMR (300.13 MHz, CDCl3, 25ºC): 
 1.14-1.29 (m, 6H), 2.20 (s, 3H), 3.14 (d, 3JH,H 7.2 Hz, 2H), 3.76 (t, 
3
JH,H 7.2 Hz, 1H), 4.98-5.12 
(m, 1H), 7.18-7.31 (m, 5H). 13C-NMR (75.5 MHz, CDCl3, 25ºC):  21.4 (CH3), 21.5 (CH3), 29.3 
(CH3), 33.7 (CH2), 61.4 (CH), 69.0 (CH), 128.0 (2CHar), 128.5 (2CHar), 128.7 (CHar), 138.1 (Car), 
168.6 (CO), 202.3 (CO). MS (ESI+, m/z): 257 [(M+Na)+, 100%]. HRMS (ESI+) calcd. for 
C14H18NaO3 (M+Na)
+: 257.1148; found: 257.1169. 
rac-Benzyl 2-methyl-3-oxobutanoate, rac-10a. Rf (8:2 hexane-EtOAc): 0.35. Colourless liquid. 
IR (KBr):  3050, 2990, 1744, 1715, 1498, 1455, and 1359 cm
-1
. 1H-NMR (300.13 MHz, CDCl3, 
25ºC):  1.36 (d, 3JH,H 7.1 Hz, 3H), 2.19 (s, 3H), 3.55 (q, 
3
JH,H 7.1 Hz, 1H), 5.17 (s, 2H), 7.32-7.37 
(m, 5H). 13C-NMR (75.5 MHz, CDCl3, 25ºC):  12.6 (CH3), 28.3 (CH3), 53.5 (CH), 70.0 (CH2), 
128.2 (CHar), 128.4 (2CHar), 128.5 (2CHar), 134.0 (Car), 170.3 (CO), 203.3 (CO). MS (ESI
+, m/z): 
229 [(M+Na)+, 100%]. 
 
2.7. General procedure for the synthesis of racemic diesters rac-1-7b and rac-9-10b. 
For the preparation of the diesters rac-2-3b, rac-5-7b and rac-9b, a two-step procedure starting 
from commercially available rac-lactic acid, rac-2-hydroxybutanoic acid or rac-phenyllactic acid 
was carried out.  
Step 1: Synthesis of α-hydroxy esters rac-2-3c, rac-5-7c, and rac-9c. 
To a solution of the corresponding acid (1.0 g, 1.0 equiv) in 40.0 mL of MeOH, EtOH, iPrOH or 
benzyl alcohol, traces of HCl were added. The reaction was refluxed and followed by TLC 
CH2Cl2/MeOH 95:5. After 24 hours, the reaction was stopped; the solvent was evaporated under 
reduced pressure. The crude mixture was then solved in 20 mL CH2Cl2, washed with a saturated 
solution of NaHCO3 (2 × 15 mL) and extracted with CH2Cl2 (3 × 15 mL). The combined organic 
layers were dried over Na2SO4, filtered and the solvent evaporated under reduced pressure. 
Racemic α-hydroxy esters were obtained without any further purification: rac-2c (29% yield, 
328.4 mg), rac-3c (27% yield, 395.6 mg), rac-5c (52% yield, 589.0 mg), rac-6c (66% yield, 836.3 
mg), rac-7c (76% yield, 1.06 g), and rac-9c (72% yield, 893 mg).  
For the preparation of rac-1b and rac-10b, this step was not necessary since rac-methyl lactate 
and rac-benzyl 2-hydroxypropanoate were commercially available. 
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Step 2: Synthesis of diesters rac-1-7b and rac-9-10b. 
α-Hydroxy esters rac-1-3c, rac-5-7c, and rac-9-10c (300 mg, 1.0 equiv) were acylated with acetic 
anhydride (2.0 equiv) or propionic anhydride (in case of 4b) and a catalytic amount of N,N-
dimethylaminopyridine in dry CH2Cl2 (6.0 mL). Racemic diesters were achieved without any 
further purification: rac-1b (75% yield, 315.9 mg), rac-2b (21% yield, 85.4 mg), rac-3b (46% 
yield, 181.9 mg), rac-4b (22% yield, 101.5 mg), rac-5b (74% yield, 301.0 mg), rac-6b (61% 
yield, 241.2 mg), rac-7b (69% yield, 266.5 mg), rac-9b (35% yield, 126.2 mg), and rac-10b (45% 
yield, 166.5 mg). 
 
2.8. Experimental procedure for obtaining rac-ethyl 2-acetoxypent-4-enoate, rac-8b. 
For the preparation of the diester rac-8b, a two-step procedure starting from commercially 
avaliable ethyl glyoxilate was employed.  
Step 1: Synthesis of rac-ethyl 2-hydroxypent-4-enoate, rac-8c.[7] 
To a solution of ethyl glyoxylate (500 mg, 1.0 equiv) and allyltrimethylsilane (2.0 equiv) in dry 
CH2Cl2 (25 mL) at 0ºC, boron trifluoride diethyl etherate (2.0 equiv) was added dropwise. The 
solution was allowed to warm up to room temperature and then stirred for 1.5 h. The reaction was 
then quenched with a saturated aqueous solution of NH4Cl and extracted with CH2Cl2 (3 × 20 
mL). The combined organic extracts were washed with brine (50 mL), dried over Na2SO4 and 
concentrated by reduced pressure to yield a crude mixture that was purified by flash 
chromatography on silica gel with hexane/ethyl acetate 7:3 as eluent to afford ethyl 2-
hydroxypent-4-enoate, rac-8c (59% yield, 300 mg) as a colourless liquid.  
Compound 8c[7] exhibits physical and spectral properties in accordance with those reported. 
Step 2: Acylation of rac-ethyl 2-hydroxypent-4-enoate rac-8c. 
Racemic 2-hydroxypent-4-enoate rac-8c (300 mg, 1.0 equiv) was acylated with acetic anhydride 
(2 equiv) and catalytic N,N-dimethylaminopyridine in dry CH2Cl2 (6.0 mL) in order to obtain pure 





3. GC and HPLC analyses 
The following columns were used for the determination of conversions and enantiomeric excesses 
(Table S2) of some α-alkyl--keto esters, their corresponding oxidation and hydrolysis products: 
A: Restek RT-BetaDEXse (30 m x 0.25 mm x 0.25 µm, 12 psi N2) and B: Hewlett Packard HP-1 
(30 m x 0.32 mm x 0.25µm, 12.2 psi N2). 
 
Table S2. Determination of conversions and enantiomeric excesses by employing GC. 
Substrate Program[a] Column tR [min] a tR [min] b tR [min] c 
1
 50/20/3/110/0 A 35.9, 36.1 32.8 (S), 33.5 (R) 27.1 (S), 29.0 (R) 
2 50/20/3/110/0 A 37.9 35.7 (S), 36.2 (R) 26.6 (S), 28.5 (R) 
3 50/20/1/90/0 A 52.2, 52.6 49.3 (S), 50.2 (R) 34.8 (S), 39.7 (R) 
4 50/20/1/110/0 A 54.2, 57.9 51.0 (S), 52.1(R) 21.4 (S), 27.5 (R) 
5 50 Isotherm B 6.0 7.5 2.4 
6 50 Isotherm B 10.2 12.8 3.5 
7 50 Isotherm B 13.3 16.3 5.7 
8 50/25/20/200/0 B 22.7 26.6 6.6 
9 70/5/1/120/0 B 44.3 46.0 25.5 
10 70/5/1/123/0 B 35.7 37.7 33.1 
[a] Program: initial T (ºC)/ time (min)/ slope (ºC/min)/ T (ºC)/ time (min)/ 
 
For the determination of the enantiomeric excesses of compounds 5-10b (Table S3), the following 
columns were employed: column A: Chiralcel OB-H (0.46 cm x 25 cm) and column B: Chiralcel 
OD (0.46 cm x 25 cm), both from Daicel. 




T [ºC] Eluent[a] 
Retention time 
[min] 
5b A 0.7 25 n-hexane-IPA 99:1 12.9 (R); 17.7 (S) 
6b A 0.5 25 n-hexane-IPA 99:1 17.8 (R); 21.1 (S) 
7b A 0.5 20 n-hexane-IPA 99:1 12.7 (R); 14.3 (S) 
8b A 0.5 20 n-hexane-IPA 99:1 22.6 (R); 26.3 (S) 
9b B 1.0 25 n-hexane-IPA 99:1 25.8 (R); 34.8 (S) 
10b A 0.8 20 n-hexane-IPA 95:5 23.8 (R); 26.3 (S) 
          [a] All the experiments were performed with isocratic eluent. 
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4. Determination of absolute configurations 
 
Absolute configurations of acylated 2-hydroxy esters 1-7b and 9-10b were established by 
comparison of their HPLC or GC retention times with the ones obtained after the esterification 
and/or acetylation of the corresponding commercial chiral α-hydroxy esters/acids.  
Absolute configuration of ethyl 2-acetoxypent-4-enoate 8b was obtained comparing the retention 
times on HPLC with the product achieved after hydrolysis of the racemic compound 8b 
employing lipase AK from Pseudomonas fluorescens.[8]  
Absolute configurations of α-hydroxy esters were achieved by its previous derivatisation into the 
corresponding acetate or propionate derivatives. 
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